Latest filing published 21 Mar 2023 for Sanara MedTech Inc., €7,859.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Rebecca E. McMahon: trading record in brief
Rebecca E. McMahon is a declared insider of Sanara MedTech Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 24 August 2021 to 17 March 2023, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 21 March 2023 came the latest disclosure, a share grant for €7,859 in Sanara MedTech Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rebecca E. McMahon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 201 shares@ US$41.50100.0% of flowCommon StockSEC:0001493152-23-008368:0
- 2,410 shares0Common StockSEC:0001493152-23-006861:0
- 2,047 shares0Common StockSEC:0001493152-22-006536:0
- 5,339 shares0Common StockSEC:0001654954-21-009470:0
4 of 4 declarations
